580 related articles for article (PubMed ID: 16190896)
1. The anti-epileptic actions of neuropeptide Y in the hippocampus are mediated by Y and not Y receptors.
El Bahh B; Balosso S; Hamilton T; Herzog H; Beck-Sickinger AG; Sperk G; Gehlert DR; Vezzani A; Colmers WF
Eur J Neurosci; 2005 Sep; 22(6):1417-30. PubMed ID: 16190896
[TBL] [Abstract][Full Text] [Related]
2. Differential suppression of seizures via Y2 and Y5 neuropeptide Y receptors.
Woldbye DP; Nanobashvili A; Sørensen AT; Husum H; Bolwig TG; Sørensen G; Ernfors P; Kokaia M
Neurobiol Dis; 2005 Dec; 20(3):760-72. PubMed ID: 15979311
[TBL] [Abstract][Full Text] [Related]
3. Neuropeptide Y regulates recurrent mossy fiber synaptic transmission less effectively in mice than in rats: Correlation with Y2 receptor plasticity.
Tu B; Jiao Y; Herzog H; Nadler JV
Neuroscience; 2006 Dec; 143(4):1085-94. PubMed ID: 17027162
[TBL] [Abstract][Full Text] [Related]
4. Blockade of neuropeptide Y(2) receptors and suppression of NPY's anti-epileptic actions in the rat hippocampal slice by BIIE0246.
El Bahh B; Cao JQ; Beck-Sickinger AG; Colmers WF
Br J Pharmacol; 2002 Jun; 136(4):502-9. PubMed ID: 12055128
[TBL] [Abstract][Full Text] [Related]
5. Differential actions of NPY on seizure modulation via Y1 and Y2 receptors: evidence from receptor knockout mice.
Lin EJ; Young D; Baer K; Herzog H; During MJ
Epilepsia; 2006 Apr; 47(4):773-80. PubMed ID: 16650144
[TBL] [Abstract][Full Text] [Related]
6. Functional interaction between neuropeptide Y receptors and modulation of calcium channels in the rat hippocampus.
Silva AP; Carvalho AP; Carvalho CM; Malva JO
Neuropharmacology; 2003 Feb; 44(2):282-92. PubMed ID: 12623227
[TBL] [Abstract][Full Text] [Related]
7. Neuroprotective effects of neuropeptide Y-Y2 and Y5 receptor agonists in vitro and in vivo.
Smiałowska M; Domin H; Zieba B; Koźniewska E; Michalik R; Piotrowski P; Kajta M
Neuropeptides; 2009 Jun; 43(3):235-49. PubMed ID: 19318226
[TBL] [Abstract][Full Text] [Related]
8. Neuropeptide Y suppresses absence seizures in a genetic rat model primarily through effects on Y receptors.
Morris MJ; Gannan E; Stroud LM; Beck-Sickinger AG; O'Brien TJ
Eur J Neurosci; 2007 Feb; 25(4):1136-43. PubMed ID: 17331209
[TBL] [Abstract][Full Text] [Related]
9. Neuropeptide Y suppresses epileptiform activity in rat hippocampus in vitro.
Klapstein GJ; Colmers WF
J Neurophysiol; 1997 Sep; 78(3):1651-61. PubMed ID: 9310450
[TBL] [Abstract][Full Text] [Related]
10. Antiepileptic actions of neuropeptide Y in the mouse hippocampus require Y5 receptors.
Baraban SC
Epilepsia; 2002; 43 Suppl 5():9-13. PubMed ID: 12121287
[TBL] [Abstract][Full Text] [Related]
11. Neuropeptide Y-induced enhancement of the evoked release of newly synthesized dopamine in rat striatum: mediation by Y2 receptors.
Adewale AS; Macarthur H; Westfall TC
Neuropharmacology; 2007 May; 52(6):1396-402. PubMed ID: 17382974
[TBL] [Abstract][Full Text] [Related]
12. Y5 receptors mediate neuropeptide Y actions at excitatory synapses in area CA3 of the mouse hippocampus.
Guo H; Castro PA; Palmiter RD; Baraban SC
J Neurophysiol; 2002 Jan; 87(1):558-66. PubMed ID: 11784771
[TBL] [Abstract][Full Text] [Related]
13. Infusion of neuropeptide Y into CA3 region of hippocampus produces antidepressant-like effect via Y1 receptor.
Ishida H; Shirayama Y; Iwata M; Katayama S; Yamamoto A; Kawahara R; Nakagome K
Hippocampus; 2007; 17(4):271-80. PubMed ID: 17265460
[TBL] [Abstract][Full Text] [Related]
14. Sigma 1 receptor-mediated increase in hippocampal extracellular dopamine contributes to the mechanism of the anticonvulsant action of neuropeptide Y.
Meurs A; Clinckers R; Ebinger G; Michotte Y; Smolders I
Eur J Neurosci; 2007 Dec; 26(11):3079-92. PubMed ID: 18005069
[TBL] [Abstract][Full Text] [Related]
15. Neuropeptide Y expression in mouse hippocampus and its role in neuronal excitotoxicity.
Wu YF; Li SB
Acta Pharmacol Sin; 2005 Jan; 26(1):63-8. PubMed ID: 15659116
[TBL] [Abstract][Full Text] [Related]
16. Neuropeptide Y(5) receptors reduce synaptic excitation in proximal subiculum, but not epileptiform activity in rat hippocampal slices.
Ho MW; Beck-Sickinger AG; Colmers WF
J Neurophysiol; 2000 Feb; 83(2):723-34. PubMed ID: 10669488
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of neuropeptide Y levels and modulation of glutamate release through neuropeptide Y receptors in the hippocampus of kainate-induced epileptic rats.
Silva AP; Xapelli S; Pinheiro PS; Ferreira R; Lourenço J; Cristóvão A; Grouzmann E; Cavadas C; Oliveira CR; Malva JO
J Neurochem; 2005 Apr; 93(1):163-70. PubMed ID: 15773916
[TBL] [Abstract][Full Text] [Related]
18. Energy metabolic profile of mice after chronic activation of central NPY Y1, Y2, or Y5 receptors.
Henry M; Ghibaudi L; Gao J; Hwa JJ
Obes Res; 2005 Jan; 13(1):36-47. PubMed ID: 15761161
[TBL] [Abstract][Full Text] [Related]
19. Neuropeptide Y and seizures: effects of exogenously applied ligands.
Woldbye DP; Kokaia M
Neuropeptides; 2004 Aug; 38(4):253-60. PubMed ID: 15337377
[TBL] [Abstract][Full Text] [Related]
20. Effects of the neuropeptide Y Y2 receptor antagonist BIIE0246 on sympathetic transmitter release in the pig in vivo.
Malmström RE; Lundberg JN; Weitzberg E
Naunyn Schmiedebergs Arch Pharmacol; 2002 Feb; 365(2):106-11. PubMed ID: 11819028
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
